The health tracking platform combines traditional bloodwork with continuous data from wearables, aiming to bridge the gap between testing and day-to-day behavior
Health technology company Ultrahuman has announced the expansion of its Blood Vision platform to 48 U.S. states. The service, which initially launched in limited regions, integrates lab-based blood analysis with data from wearables like the Ultrahuman Ring and M1 continuous glucose monitor (CGM), enabling users to track changes in health indicators over time.
Unlike typical blood tests that capture a single moment in time, Blood Vision is designed to offer a more comprehensive view of health through repeat testing and the ongoing collection of lifestyle data. The platform includes a panel of over 100 clinically validated biomarkers across cardiovascular, metabolic, hormonal, inflammatory and aging-related systems. These include markers such as ApoB, hs-CRP and fasting insulin.
Ultrahuman’s UltraTrace technology links these biomarkers to real-time metrics like sleep, activity and glucose levels, creating a feedback loop that encourages behavioral adjustments between tests. Users can monitor trends through the Ultrahuman app, which presents data in a dashboard and includes summaries from clinicians, as well as optional coaching to interpret results.
“Traditional diagnostics offer a moment-in-time snapshot,” said Mohit Kumar, Founder and CEO of Ultrahuman. “Blood Vision transforms this into a longitudinal, predictive model of your health, where insights evolve as you do and interventions are guided by both real-time lifestyle data and blood marker analysis. The real magic is in between two blood vision tests. Tracking lifestyle biomarkers between two tests allows us to establish the relationship between the biomarkers and lifestyle changes. Most people lose track of what to change between two tests, blood vision bridges this gap.”
Blood Vision is now available to most U.S. consumers (state-specific regulations prevent access in Rhode Island). Ultrahuman says the expansion is part of its broader goal to create a comprehensive platform for self-monitoring and health management.
